Evidence map›Paper›PMID 38214058›Full record

ArticleDisease models & mechanisms2024

A Zika virus protein expression screen in Drosophila to investigate targeted host pathways during development.

Nichole Link, J Michael Harnish, Brooke Hull, Shelley Gibson, Miranda Dietze, Uchechukwu E Mgbike, Silvia Medina-Balcazar, Priya S Shah, Shinya Yamamoto

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Frontiers in microbiology · 2025
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Nichole LinkDepartment of Neurobiology, University of Utah, Salt Lake City, UT, 84112, USA.ORCID 0000-0002-4825-9615
J Michael HarnishDepartment of Molecular and Human Genetics, BCM, Houston, TX, 77030, USA.ORCID 0000-0002-6241-188X
Brooke HullDepartment of Molecular and Human Genetics, BCM, Houston, TX, 77030, USA.ORCID 0000-0003-2040-5198
Shelley GibsonDepartment of Molecular and Human Genetics, BCM, Houston, TX, 77030, USA.ORCID 0000-0002-9135-3906
Miranda DietzeDepartment of Neurobiology, University of Utah, Salt Lake City, UT, 84112, USA.ORCID 0000-0002-3798-5240
Uchechukwu E MgbikeDepartment of Neurobiology, University of Utah, Salt Lake City, UT, 84112, USA.
Silvia Medina-BalcazarDepartment of Molecular and Human Genetics, BCM, Houston, TX, 77030, USA.
Priya S ShahDepartment of Chemical Engineering, Department of Microbiology and Molecular Genetics, University of California, Davis, CA, 95616, USA.ORCID 0000-0001-7518-2839
Shinya YamamotoDepartment of Molecular and Human Genetics, BCM, Houston, TX, 77030, USA.ORCID 0000-0003-2172-8036
Neurological Research Institute · USUniversity of Utah · USBaylor College of Medicine · USHoward Hughes Medical Institute · USUniversity of California, Davis · US

Funding

Preclinical and Clincial OutcomesP50HD103555 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MIRJANA MALETIC-SAVATIC · 2020 to 2026
$9.9M
DEVELOPMENTAL BIOLOGY TRAINING PROGRAMT32HD007491 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI James Alan Gagnon, Kristen M Kwan · 1995 to 2026
$8.0M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, SAMACO, RODNEY C · 2014 to 2019
$7.8M
YEARS 19 - 23: BCM POST-BACCALAUREATE RESEARCH EDUCATION PROGRAMR25GM069234 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PEREIRA, FRED A · 2003 to 2024
$7.5M
Molecular mechanisms linking viral replication and neuropathogenesisR01AI170857 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Priya Shirish Shah · 2023 to 2026
$2.1M
Molecular mechanisms linking viral replication and neuropathogenesisR56AI170857 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SHAH, PRIYA SHIRISH · 2022 to 2022
$528k
NIAID NIH HHS R01 AI170857NIAID NIH HHS R56 AI170857NICHD NIH HHS P50 HD103555NICHD NIH HHS T32 HD007491NICHD NIH HHS U54 HD083092NIGMS NIH HHS R25 GM069234NIGMS NIH HHS R25GM069234
6 · The paper itself

Abstract

In the past decade, Zika virus (ZIKV) emerged as a global public health concern. Although adult infections are typically mild, maternal infection can lead to adverse fetal outcomes. Understanding how ZIKV proteins disrupt development can provide insights into the molecular mechanisms of disease caused by this virus, which includes microcephaly. In this study, we generated a toolkit to ectopically express ZIKV proteins in vivo in Drosophila melanogaster in a tissue-specific manner using the GAL4/UAS system. We used this toolkit to identify phenotypes and potential host pathways targeted by the virus. Our work identified that expression of most ZIKV proteins caused scorable phenotypes, such as overall lethality, gross morphological defects, reduced brain size and neuronal function defects. We further used this system to identify strain-dependent phenotypes that may have contributed to the increased pathogenesis associated with the outbreak of ZIKV in the Americas in 2015. Our work demonstrates the use of Drosophila as an efficient in vivo model to rapidly decipher how pathogens cause disease and lays the groundwork for further molecular study of ZIKV pathogenesis in flies.

Indexed as

MicrocephalyZika VirusZika Virus InfectionAnimalsDrosophilaDrosophila melanogasterDegenerationDrosophilaMicrocephalyVirus-host targetsZika virus

Identifiers

PMID38214058
PMCPMC10924231
OpenAlexW4390789577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.